Skip to main content
. 2020 Nov 17;11(46):4306–4324. doi: 10.18632/oncotarget.27811

Figure 9. The docking result of miR-32-AURKA and hAgo2.

Figure 9

The binding position of the complex in the pocket of hAgo2 (A); Residual amino acids participating in their interaction (B); Amino acid residues (C).